Stephen Carro

Mr. Stephen Carro

University of Pennsylvania Perelman School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Viruses
Verified
Journal Article
Open access
PDF file
SCStephen Carro
Stephen Carro
SCSara Cherry
Sara Cherry
Flaviviruses are a group of positive-sense RNA viruses that are primarily transmitted through arthropod vectors and are capable of causing a broad spectrum of diseases. Many of the flaviviruses that are pathogenic in humans are transmitted specifically through mosquito vectors. Over the past century, many mosquito-borne flavivirus infections have emerged and re-emerged, and are of global importance with hundreds of millions of infections occurring yearly. There is a need for novel, effective, and accessible vaccines and antivirals capable of inhibiting flavivirus infection and ameliorating disease. The development of therapeutics targeting viral entry has long been a goal of antiviral research, but most efforts are hindered by the lack of broad-spectrum potency or toxicities associated with on-target effects, since many host proteins necessary for viral entry are also essential for host cell biology. Mosquito-borne flaviviruses generally enter cells by clathrin-mediated endocytosis (CME), and recent studies suggest that a subset of these viruses can be internalized through a specialized form of CME that has additional dependencies distinct from canonical CME pathways, and antivirals targeting this pathway have been discovered. In this review, we discuss the role and contribution of endocytosis to mosquito-borne flavivirus entry as well as consider past and future efforts to target endocytosis for therapeutic interventions.

3 October 2017 in Metabolomics
Verified
Journal Article
Closed access
PDF file
Emily Rose SekeraEmily Rose Sekera
Emily Rose Sekera
HRHeather L. Rudolph
Heather L. Rudolph
SCStephen Carro
Stephen Carro
MMMichael J. Morales
Michael J. Morales
GBGlenna C. L. Bett
Glenna C. L. Bett
Troy Dale WoodTroy Dale Wood
Troy Dale Wood

29 May 2026 in Science Immunology
Verified
Journal Article
Closed access
ACAngela Corrigan
Angela Corrigan
SNShin Foong Ngiow
Shin Foong Ngiow
MSMaura Statzu
Maura Statzu
AAAmie Albertus
Amie Albertus
MPM. Betina Pampena
M. Betina Pampena
MBMichael R. Betts
Michael R. Betts
Selective in vivo reprogramming of cytotoxic effector CD8 T (T eff ) cells holds tremendous promise as a therapeutic tool but has not yet been accomplished. Here, we demonstrate that fractalkine-conjugated mRNA lipid nanoparticles (mRNA-LNPs) can specifically target and deliver mRNA to CX3CR1 + T eff cells in vitro and in vivo. In mice, fractalkine-conjugated mRNA-LNPs targeted up to 95% of blood and splenic T eff cells. In addition, delivery of IL-2–encoding mRNA and human CD62L-encoding mRNA to mouse T eff cells enabled robust exogenous IL-2 secretion and CD62L expression. In rhesus macaques, fractalkine-conjugated mRNA-LNPs targeted up to ~100% of peripheral blood T eff cells, and delivery of human CD62L-encoding mRNA enabled cell-surface human CD62L expression on peripheral blood T eff cells and detection of human CD62L + T eff cells in lymphoid tissue. Collectively, these data demonstrate the potential of natural receptor ligand-based targeting of mRNA-LNPs for rapid, efficient, and transient in vivo modification of T eff cells.

4 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
LELaurence Eisenlohr
Laurence Eisenlohr
SCStephen Carro
Stephen Carro
EHEmma Hedgepeth
Emma Hedgepeth
CLCandy Lucero-Sanchez
Candy Lucero-Sanchez
MHMary Heard
Mary Heard
EPElise Peauroi
Elise Peauroi
Orthopoxviruses, including variola and monkeypox, have long ravaged human populations for reasons that remain unclear. Members of the highly conserved B22 protein family are notable for their extreme virulence via targeting of multiple host defenses. C15, the B22 protein of ectromelia (murine model for smallpox), is known to target NK cells and CD4+ T cells, and, as shown here, also CD8+ T cells. Unexpectedly, in C57Bl/6 mice, T cell responses were larger, more functional, and phenotypically enhanced in the face of C15 expression. cDC1-mediated cross-presentation contributed to enhanced CD8+ T cell responses, but the primary contributor was C15-mediated antagonism of NK cell-dependent viral control, and single cell analysis identified a potential signaling scaffold downstream of C15 inhibitory activity. Conversely, in BALB/c mice, which mount suboptimal NK cell responses, T cells were more prominently inhibited. These studies introduce the concept of conditional immunomodulation dictated by the immunocompetence profile of the host.

30 June 2026 in bioRxiv
Verified
Preprint
Open access
LYLinlin Yang
Linlin Yang
MHMichael J. Hogan
Michael J. Hogan
SCStephen Carro
Stephen Carro
EHEmma J. Hedgepeth
Emma J. Hedgepeth
JDJianqiu Du
Jianqiu Du
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
CD4 + T cells coordinate immune responses to infections and cancers and initiate many autoimmune diseases, yet the intracellular pathways that generate the peptide antigens they recognize remain incompletely understood. Progress has been limited in part by the scarcity of reagents that directly detect defined peptide:MHC class II (pMHC-II) complexes. Here, we established an mRNA vaccine-based pipeline to generate and characterize T cell receptor (TCR)-like antibodies. One result was 1D6, a monoclonal antibody specific for NA25:A b , an influenza A/PR8 neuraminidase-derived epitope presented by MHC-II. 1D6 bound NA25:A b with high affinity and specificity. 1D6 recognizes NA25:A b through binding determinants partially distinct from those used by the cognate TCR. Using this reagent, we confirmed the proteasome dependence of NA25 presentation and showed that NA25:A b accumulates in intracellular MHC-II loading compartments without a major requirement for canonical macroautophagy, pointing to an unconventional mode of antigen presentation. These findings establish TCR-like antibodies as powerful tools for dissecting noncanonical MHC-II antigen processing pathways. One Sentence Summary: An mRNA immunization strategy generated a highly specific antibody to study how a noncanonical natural epitope from influenza virus is produced and loaded onto MHC-II.

27 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EPElise M. Peauroi
Elise M. Peauroi
SCStephen Carro
Stephen Carro
LPLuxin Pei
Luxin Pei
GRGlennys V. Reynoso
Glennys V. Reynoso
HHHeather D. Hickman
Heather D. Hickman
LELaurence C. Eisenlohr
Laurence C. Eisenlohr
The success of poxviruses as pathogens depends upon their antagonism of host responses by multiple immunomodulatory proteins. The largest of these expressed by ectromelia virus (the agent of mousepox) is C15, one member of a well-conserved poxviral family previously shown to inhibit T cell activation. Here, we demonstrate by quantitative immunofluorescence imaging that C15 also limits contact between natural killer (NK) cells and infected cells in vivo . This corresponds to an inhibition in the number of total and degranulating NK cells, ex vivo and in vitro , with no detectable impact on NK cell cytokine production nor the transcription of factors related to NK cell recruitment or activation. Thus, in addition to its previously identified capacity to antagonize CD4 T cell activation, C15 inhibits NK cell cytolytic function, which results in increased viral replication and dissemination in vivo . This work builds on a body of literature demonstrating the importance of early restriction of virus within the draining lymph node. summary: Poxvirus B22 family proteins are important virulence factors known to inhibit T cell functions. Peauroi et al. identify a novel function of the ectromelia virus homolog, C15, which inhibits NK cell-target contact and cytolytic function to facilitate early viral spread. (Provide a short, ∼40-word summary statement for the online JEM table of contents and alerts. This summary should describe the context and significance of the findings for a general readership; it should be written in the present tense and refer to the work in the third person.)